Menu

Month: January 2024

News Alert

Senior HRSA Official Doubles Down on Agency’s 340B Patient Definition in Wake of Genesis Ruling

William Newton Washington Correspondent Views
Rear Admiral Krista Pedley saluting
Rear Adm. Krista Pedley, director of HRSA's Office of Special Health Initiatives, addressed the 340B patient definition at a conference Tuesday.
A high-ranking Health Resources & Services Administration (HRSA) official this morning told 340B stakeholders that the agency would continue to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Former Sen. Cassidy Aide, Trump Administration Executive Criticizes Requiring More Hospital 340B Reporting

Rich Daly Editor in Chief Views
Brenda Destro, a former aide to a Republican senator and HHS official, recently wrote an op-ed that criticized hospital 340B transparency legislation.
A former Trump administration Health and Human Service Department (HHS) executive and adviser to Sen. Bill Cassidy (R-LA) published a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

Rich Daly Editor in Chief Views
Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.
The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Prepping for HRSA Audits

Sponsored Content Views
Three Considerations for 2024

SPONSORED CONTENT

Are you truly ready for a HRSA audit? Today we have two 340B experts, Dennis Killian and Heather Erickson, from CPS Solutions, LLC. (CPS) here to discuss three topics that will help you prepare. CPS has managed 340B Programs for hospitals and health systems since the program’s inception, ensuring compliance with the 340B statute, HRSA guidance, as well as best practices from across the industry.

The following is a transcript of the above video:

Dennis Killian: Hi, everybody. My name is Dennis Killian. I’m a pharmacist with the CPS Solutions, LLC. (CPS) 340B team, and I work with a lot of covered entities across the nation. We help them with a variety of different services, whether it’s compliance monitoring or to help them optimize their program, basically whatever they need.

Heather

…
Read More »

Health Systems, HRSA Spar in Federal Court Over 340B Registration Policy Reversal

William Newton Washington Correspondent Views
U.S. District Court of the District of Columbia
A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.
Forty-four health systems have asked a federal district court to decide, without a full trial, on their lawsuit against federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

340B Hospitals Had Largest Markups of High-Cost Infused Drugs: Study

Rich Daly Editor in Chief Views
A New England Journal of Medicine study found that 340B hospitals had larger price markups than other hospitals or physician practices for certain high-cost infusion drugs.
340B hospitals had larger price markups than other hospitals or physician practices for 57 high-cost infusion drugs, according to a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

GSK, Vertex Offer Refunds to 340B Providers

Rich Daly Editor in Chief Views
GSK headquarters
GSK was one of two drugmakers to issue refunds to 340B covered entities, according to notices posted on a government regulatory site.
Drugmakers GlaxoSmithKline and Vertex Pharmaceuticals will offer refunds to 340B providers related to the purchases of several of their high-earning [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

COLUMN: Action on 340B Contract Pharmacies Turns to the States

Ted Slafsky Publisher & CEO Views
Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Exclusive

Genesis CEO Praises Court Decision, Blasts HRSA, NACHC, State Primary Care Association

Rich Daly Editor in Chief Views
Tony Megna, CEO and general counsel of Genesis Healthcare, shared his first public comments with 340B Report on a key 340B court decision.
In his first public comments since a key federal court decision on the 340B patient definition, the leader of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Amid Possible Coming Enforcement, PhRMA Again Asks Court to Block Louisiana’s 340B Contract Pharmacy Law

William Newton Washington Correspondent Views
In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.
After Louisiana signaled plans to possibly enforce its state 340B contract pharmacy law, a powerful drug industry trade group has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report